Healthy.Capital

Healthy.Capital is a venture capital firm established in 2017 and located in Amsterdam, Netherlands. The firm focuses on providing growth capital, co-investments, and seed or startup investments primarily in the health and care sectors, specifically targeting health tech and digital healthcare services. It aims to support companies that offer B2B and B2C solutions, with a preference for those based in the Netherlands. Healthy.Capital typically invests between €0.2 million and €2 million in businesses with an enterprise value ranging from €0.5 million to €10 million, usually taking a minority stake in these companies.

Ineke Cazander

Managing Partner

Douwe Jippes

Founder and Managing Partner

Jan Folkert Kunst

Co-Founder and Partner

Thom Nefkens

Co-Founder, Board Member and Managing Partner

Alexander Van Der Wyck

Principal

9 past transactions

VRelax

Seed Round in 2024
VRelax is a science-based platform that utilizes virtual reality to assist individuals in managing mental and physical health challenges. The company offers a diverse selection of virtual nature environments and exercises aimed at reducing stress levels and enhancing mood. Users can access these immersive experiences anytime and anywhere, providing a convenient tool for coping with various stressors. Through its innovative approach, VRelax seeks to deliver effective relief and support to those in need.

HealthSage AI

Seed Round in 2024
HealthSage AI is an open platform focused on generative artificial intelligence in the healthcare sector. It provides a secure and transparent foundation for the healthcare and open-source communities, facilitating the development and collaboration of various AI applications. The platform enables healthcare professionals to analyze extensive unstructured data and seamlessly integrate it with existing healthcare information systems, thereby enhancing the overall effectiveness of healthcare delivery. Through its innovative approach, HealthSage AI aims to transform the landscape of healthcare technology.

Homed-IQ

Seed Round in 2023
Homed-IQ is an e-commerce platform specializing in health test kits designed to facilitate self-health monitoring. The company offers a range of wellness products that include testing kits for various health concerns such as anemia, antibodies, celiac disease, diabetes, vitamins, cholesterol, allergies, and liver and kidney function. By providing these testing solutions, Homed-IQ enables individuals to conveniently assess their health from home, making it easier for them to stay informed about their wellness.

Roott

Pre Seed Round in 2023
Roott provides a diverse spectrum of psychologists and therapists specializing in diet, hormones, stress, sleep, and exercise. Roott's mission is to empower people to properly manage their mental and physical health.

Nori Health

Seed Round in 2021
Nori Health operates a healthcare platform designed to provide personalized support for individuals living with chronic diseases, particularly those with inflammatory bowel disease. The platform features a chatbot that engages users in regular conversations, helping them identify and modify lifestyle factors that may exacerbate their condition. By facilitating these lifestyle changes, Nori Health aims to improve patients' overall quality of life and alleviate symptoms such as fatigue, pain, and anxiety. The service focuses on empowering users to take control of their health through tailored guidance and support.

Clear

Venture Round in 2021
Clear B.V., founded in 2019 and based in Amsterdam, the Netherlands, provides personalized food recommendation plans aimed at promoting healthier lifestyles. The company utilizes intelligent, AI-driven programs to help users manage various aspects of their health, including nutrition, exercise, sleep, and stress. Unlike traditional activity trackers, Clear leverages biomarkers from wearables to deliver precise insights and recommendations. Its programs cater to specific needs, such as diabetes prevention, professional sports performance, and optimizing ketogenic diets. By integrating scientific use cases, Clear offers users actionable guidance rather than mere data, effectively connecting the relationships between sleep, diet, exercise, and stress.

MiGuide

Seed Round in 2020
MiGuide is a digital lifestyle coaching platform designed for individuals with type 2 diabetes. Founded in 2016 and headquartered in Rotterdam, Netherlands, MiGuide offers an application that assists users in managing various aspects of their health. The platform provides guidance on exercise, nutrition, sleep, stress management, and blood sugar level maintenance, aiming to help users maintain an active and healthy lifestyle. By focusing on these key areas, MiGuide enables diabetic patients to better manage their condition and improve their overall well-being.

Clear

Seed Round in 2020
Clear B.V., founded in 2019 and based in Amsterdam, the Netherlands, provides personalized food recommendation plans aimed at promoting healthier lifestyles. The company utilizes intelligent, AI-driven programs to help users manage various aspects of their health, including nutrition, exercise, sleep, and stress. Unlike traditional activity trackers, Clear leverages biomarkers from wearables to deliver precise insights and recommendations. Its programs cater to specific needs, such as diabetes prevention, professional sports performance, and optimizing ketogenic diets. By integrating scientific use cases, Clear offers users actionable guidance rather than mere data, effectively connecting the relationships between sleep, diet, exercise, and stress.

Orikami.nl

Seed Round in 2019
Orikami B.V., founded in 2011 and based in Nijmegen, the Netherlands, specializes in data science consultancy and digital health solutions tailored for the healthcare industry. The company provides three primary service lines that harness advanced data science expertise, focusing on digital biomarkers and medical-grade technology aimed at chronic disease management. Orikami's artificial intelligence-driven platform facilitates the discovery, validation, and scalable delivery of digital biomarkers, enhancing decision support, treatment strategies, and patient coaching for medical specialists. Committed to data security and quality management, Orikami adheres to ISO27001 and ISO13485 standards in its operations.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.